Table 3

Characteristics of the IDDM patients grouped by the severity of the diabetic retinopathy

Normal subjects IDDM none to minimal non-proliferative retinopathy
(RP score 10, 20)
IDDM moderate non-proliferative retinopathy
(RP score 30)
IDDM quiescent proliferative retinopathy
(RP score 50)
IDDM severe non-proliferative or active proliferative retinopathy
(RP score 40, 60)
Subjects13913511
Age (years)34 (8)29 (6)* 35 (7)36 (7)36 (7)
Duration of diabetes (years)18 (6) 21 (8)25 (5)25 (4)
Body mass index (kg/m2)25.3 (3.2)24.5 (1.6)24.2 (3.1)24.4 (2.5)25.5 (2.0)
Body fat (%)17 (5)17 (5)19 (6)16 (4)16 (4)
HbA1c (%)5.2 (0.5) 7.8 (0.8)**, 8.8 (1.4)7.8 (0.8)9.2 (1.0)
Urinary albumin excretion (μg/min)9 (4)7 (3)10 (9)208 (349)†† 602 (1495)††
Blood pressure, systolic (mmHg)126 (18)120 (11)122 (11)128 (7)133 (19)
Blood pressure, diastolic (mmHg)72 (15)73 (9)74 (4)78 (7)79 (10)
Insulin dose (IU/ffm/d)0.75 (0.28)0.94 (0.27)0.80 (0.20)0.81 (0.16)
Serum total renin (ng/l)201 (88)‡‡ ,§ 270 (43)337 (106)338 (183)596 (268)†††,‡‡
  • p<0.001 for normal subjects vIDDM patients; **p<0.01 for IDDM patients with RP score 10 or 20v patients with RP score 40 or 60, *p<0.05 for IDDM patients with RP score 10 or 20 vpatients with RP score 40 or 60. †††p<0.001 for IDDM patients with RP score 40 or 60 v patients with RP score 10 or 20 and normal subjects, ††p<0.01 for IDDM patients with RP score 50, 40 or 60 v other IDDM patients,p<0.05 for IDDM patients with RP score 10 or 20v patients with RP score 50.‡‡p<0.001 for normal subjects v IDDM patients with RP core 30, 40, or 60, ‡‡p<0.01 for IDDM patients with RP score 40 or 60 v patients with RP score 30 or 50. p<0.05 for IDDM patients with RP score 10 or 20v patients with RP score 30. §p<0.05 for normal subjects v IDDM patients with RP score 10 or 50. Data are expressed as mean and standard deviation of the mean (SD).